Webcast CME

Best Practices in Multiple Sclerosis
3rd Annual MS Highlights Report

Best Practices in Multiple Sclerosis -
Report from ECTRIMS

 

Print this Content

Release Date:   December 21, 2016
Expiration Date:   December 21, 2017

Estimated Time of Completion:   1 hour

Description

The Best Practices in Multiple Sclerosis: Report from ECTRIMS webcast reviews the most important information presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting and identifies potential implications for clinical practice. The presentations review recent research in the areas of progressive MS, MRI imaging, neuromyelitis optica, treatments, and basic practices.

Learning Objectives

  1. Summarize the most important information presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting and their potential implications for clinical practice.
  2. Describe pros and cons of MRI technologies as an imaging study in the diagnosis of MS as well as newer techniques applicable to MS diagnosis and monitoring.
  3. Define optic neuritis, its pathology, clinical characteristics, appropriate imaging studies, diagnosis, and treatment options.
  4. Synthesize safety and efficacy data from clinical trials and assess their potential implications for clinical practice.
  5. Review emerging data on efficacy and side effects of oral agents for MS and other newer agents emerging for MS treatment.

Target Audience

This activity is intended for neurologists, internal medicine physicians, clinical researchers, and allied health professionals, including nurse practitioners and physician assistants.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Alexander D. Rae-Grant, MD, FRCP(C)
Mellen Center for Multiple Sclerosis
Center for Brain Health
Jane and Lee Seidman Chair for Neurological Education
Cleveland Clinic
Cleveland, OH

Faculty

Devon Conway, MD, MS
Assistant Professor
Cleveland Clinic Lerner College of Medicine
Staff Neurologist
Mellen Center for Multiple Sclerosis
Neurological Institute
Cleveland Clinic
Cleveland, OH

Daniel Ontaneda, MD, MSc
Staff Neurologist
Mellen Center for Multiple Sclerosis
Cleveland Clinic
Cleveland, OH

Mary Alissa Willis, MD
Staff Neurologyst
Mellen Center for Multiple Sclerosis
Cleveland Clinic
Cleveland, OH

Dean M. Wingerchuk, MD, MSc, FRCP(C)
Mayo Clinic
Phoenix/Scottsdale, AZ

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation, could be perceived as a potential conflict of interest:


Daniel Ontaneda, MD, MSc
  Biogen Idec, Genentech, Genzyme/Sanofi, Novartis Consulting
 
Mary Alissa Willis, MD
  Genzyme/Sanofi Teaching and Speaking
 
Dean M. Wingerchuk, MD, MSc, FRCP(C)
  Alexio Consulting, Independent Contractor (Including contracted
research)
  MedImmune Consulting
  Terumo Independent Contractor (Including contracted research)

The following faculty have indicated that they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Devon Conway, MD, MS
Alexander D. Rae-Grant, MD

The Cleveland Clinic Foundation Center for Continuing Education acknowledges
educational grants for partial support of this activity from
:

Genentech, Inc.
Novartis Pharmaceuticals Corporation

This CME activity was produced by the Cleveland Clinic Center for Continuing Education and
Cleveland Clinic's Mellen Center for Neurology Treatment and Research.